Apollo Medical Stock Forecast, Price & News

Wall Street analysts have given Apollo Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Apollo Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Apollo Medical saw a increase in short interest in the month of May. As of May 14th, there was short interest totaling 488,000 shares, an increase of 26.0% from the April 29th total of 387,300 shares. Based on an average daily volume of 91,800 shares, the short-interest ratio is currently 5.3 days.
View Apollo Medical's Short Interest.

Apollo Medical is scheduled to release its next quarterly earnings announcement on Friday, August 6th 2021.
View our earnings forecast for Apollo Medical.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its quarterly earnings data on Tuesday, May, 4th. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.22 by $0.08. The business had revenue of $176.06 million for the quarter. Apollo Medical had a net margin of 6.73% and a trailing twelve-month return on equity of 16.81%.
View Apollo Medical's earnings history.

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AMEH stock has increased by 243.6% and is now trading at $48.34.
View which stocks have been most impacted by COVID-19.

Apollo Medical issued an update on its second quarter 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $163 million-173 million, compared to the consensus revenue estimate of $170.90 million.

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Apollo Medical include Genpact (G), FTI Consulting (FCN), Exponent (EXPO), ICF International (ICFI), Montrose Environmental Group (MEG), The RMR Group (RMR), Huron Consulting Group (HURN), GreenBox POS (GBOX), The Hackett Group (HCKT), Tailwind Acquisition (TWND), Atlas Technical Consultants (ATCX), BlackRock Capital Investment (BKCC), Information Services Group (III), Mastech Digital (MHH) and Bowman Consulting Group (BWMN).
View all of AMEH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), The Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.71%), Ophir Asset Management Pty Ltd (0.76%), Geode Capital Management LLC (0.62%), Northern Trust Corp (0.45%), JPMorgan Chase & Co. (0.30%) and GW&K Investment Management LLC (0.26%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, John Chiang, Kenneth T Sim, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends for Apollo Medical.

AMEH stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Northern Trust Corp, Credit Suisse AG, Goldman Sachs Group Inc., Renaissance Technologies LLC, UBS Group AG, Alliancebernstein L.P., and Citigroup Inc.. Company insiders that have sold Apollo Medical company stock in the last year include Adrian Vazquez, and Physicians Of Californi Allied.
View insider buying and selling activity for Apollo Medical or view top insider-selling stocks.

AMEH stock was bought by a variety of institutional investors in the last quarter, including Ophir Asset Management Pty Ltd, GW&K Investment Management LLC, Royal Bank of Canada, Victory Capital Management Inc., Citadel Advisors LLC, Cornercap Investment Counsel Inc., D.A. Davidson & CO., and Geode Capital Management LLC. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Brandon Sim, Eric Chin, John Chiang, Kenneth T Sim, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam.
View insider buying and selling activity for Apollo Medical or or view top insider-buying stocks.

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $48.34.

Apollo Medical has a market capitalization of $2.66 billion and generates $687.18 million in revenue each year. The company earns $37.87 million in net income (profit) each year or $1.01 on an earnings per share basis.

Apollo Medical employs 630 workers across the globe.

The official website for Apollo Medical is www.apollomed.net.

Apollo Medical is headquartered at 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]